Detalles de la búsqueda
1.
An ADAM17 selective inhibitor promotes glucose uptake by activating AMPK.
J Pharmacol Sci
; 154(1): 37-46, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38081682
2.
Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report.
BMC Endocr Disord
; 22(1): 184, 2022 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35854271
3.
New classification and diagnostic criteria for insulin resistance syndrome.
Endocr J
; 69(2): 107-113, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35110500
4.
Factors Affecting Human Damage in Heavy Rains and Typhoon Disasters.
Tohoku J Exp Med
; 256(2): 175-185, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35236809
5.
Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials.
Cardiovasc Diabetol
; 20(1): 96, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33947390
6.
A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum.
Anal Biochem
; 613: 114019, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33189705
7.
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials.
Diabetes Obes Metab
; 23(12): 2785-2794, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472698
8.
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study.
Diabetes Obes Metab
; 23(7): 1496-1504, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33620762
9.
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies.
Diabetes Obes Metab
; 23(2): 549-560, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145944
10.
Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes.
Biochem Biophys Res Commun
; 530(3): 500-507, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32595040
11.
Inhibition of inflammation-mediated DPP-4 expression by linagliptin increases M2 macrophages in atherosclerotic lesions.
Biochem Biophys Res Commun
; 524(1): 8-15, 2020 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31964532
12.
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial.
Diabetes Obes Metab
; 22(9): 1516-1526, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32311204
13.
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial.
Diabetes Obes Metab
; 22(4): 540-548, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31742898
14.
Clinical Features of Disaster-Associated Direct Deaths during Recent Inland Earthquakes in Japan.
Tohoku J Exp Med
; 251(3): 169-173, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641643
15.
Impact of hepatic HSP72 on insulin signaling.
Am J Physiol Endocrinol Metab
; 316(2): E305-E318, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30532989
16.
Superior efficacy with a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin-naïve Japanese patients with type 2 diabetes in a phase 3, open-label, randomized trial.
Diabetes Obes Metab
; 21(12): 2674-2683, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31407845
17.
Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes.
Diabetes Obes Metab
; 21(4): 876-882, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30499157
18.
Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE study.
Diabetes Obes Metab
; 21(7): 1737-1744, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30830727
19.
Inhibition of Local Macrophage Growth Ameliorates Focal Inflammation and Suppresses Atherosclerosis.
Arterioscler Thromb Vasc Biol
; 38(5): 994-1006, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29496659
20.
Hyperemesis gravidarum followed by refeeding syndrome causes electrolyte abnormalities induced rhabdomyolysis and diabetes insipidus.
Endocr J
; 66(3): 253-258, 2019 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30700639